All Posts By

Smartkarma Daily Briefs

Daily Brief Energy/Materials: JX Advanced Metals, Kenmare Resources , De Grey Mining, Hanwha Energy, Natural Gas, Crude Oil, Gold, Iron Ore, YPF SA and more

By | Daily Briefs, Energy & Materials Sector

In today’s briefing:

  • JX Advanced Metals (5016 JP) IPO: Big Retail Allocation Means No Fast Entry
  • Will a 93% takeover premium spur M&A drama?
  • De Grey Mining (DEG AU): Scheme Vote on 16 April
  • Initial Thoughts on the Hanwha Energy IPO
  • De Grey Mining (DEG AU): 16th April Scheme Vote
  • [US Nat Gas Options Weekly 2025/10] Henry Hub Rallies on Colder Weather and Record LNG Exports
  • [US Crude Oil Options Weekly 2025/10] WTI Extends Decline Amid Weak Demand and Trade Uncertainty
  • Gold’s Record Rally Meets Resistance: Will USD 3,000 Be the Breaking Point?
  • Iron Ore Majors Guidance: Key To Understanding Supply Side in 2025
  • YPF 4Q24: Macro Tailwinds and Strategic Progress Offset a Weak Quarter


JX Advanced Metals (5016 JP) IPO: Big Retail Allocation Means No Fast Entry

By Brian Freitas

  • JX Advanced Metals (5016 JP) has priced its IPO at ¥820/share, at the top end of the IPO range but lower than the initial indication of ¥862/share.
  • With the bulk of the domestic offering going to retail investors, there is no chance of Fast Entry for the stock in global indices.
  • TOPIX INDEX inclusion will take place at the close on 28 April, while inclusion in major global indices is likely to take place in August and September.

Will a 93% takeover premium spur M&A drama?

By Money of Mine

  • Oryx Global Partners teams up with former Kenmare Resources MD Michael Carville for takeover bid
  • Kenmare Resources operates moma titanium mine in Mozambique, one of the world’s largest producers
  • Weak mineral sands market and political upheaval in Mozambique impact company’s operations and valuation, leading to potential takeover bid

This content is sourced through publicly available sources and has been machine generated. Information displayed is for general informational purposes only.


De Grey Mining (DEG AU): Scheme Vote on 16 April

By Arun George

  • The De Grey Mining (DEG AU) IE considers Northern Star Resources (NST AU)’s offer fair and reasonable. The offer is 0.119 NST shares per DEG share.
  • The key condition is DEG shareholder approval. Due to the lack of a competing bid, Gold Road Resources (GOR AU), which holds a potentially blocking stake, should support it.
  • The offer is attractive compared to historical trading ranges. At the last close and for a 5 May payment, the gross/annualised spread is 2.4%/18.2%.

Initial Thoughts on the Hanwha Energy IPO

By Douglas Kim

  • Hanwha Energy, which is 100% owned by the Hanwha Group owner family members, has started the process of going public. Hanwha Energy could complete its IPO in 2025/2026. 
  • One of the scenarios involving Hanwa Energy is that once it completes its IPO, it could merge with Hanwha Corporation (000880 KS). 
  • Hanwha Energy generated revenue of 4.7 trillion won (up 20% YoY) and operating profit of 215 billion won (up 306.5% YoY). 

De Grey Mining (DEG AU): 16th April Scheme Vote

By David Blennerhassett

  • Back on the 2nd Dec 2024, De Grey Mining (DEG AU), which boasts one of Australia’s largest undeveloped gold projects, announced a merger with Northern Star Resources (NST AU).
  • Northern Star offered 0.119 new shares for every De Grey share, and will hold ~80.1% of the combined entity upon a successful Scheme, with De Grey shareholders the remaining ~19.9%.
  • The Scheme Booklet is now out, with a Scheme Meeting on the 16th April. Expected implementation on the 5th May. The IE (KPMG) says fair & reasonable.

[US Nat Gas Options Weekly 2025/10] Henry Hub Rallies on Colder Weather and Record LNG Exports

By Suhas Reddy

  • For the week ending 07/Mar, U.S. natural gas prices surged by 14.7% on the back of colder weather forecasts, rising LNG exports, and supply constraints.
  • Henry Hub posted its biggest weekly gain since January, hitting a 26-month high during the week ending 07/Mar. Prices closed above the 9-day and 21-day moving averages.
  • Henry Hub OI PCR was 1.00 on 07/Mar, unchanged from 28/Feb. Call OI rose by 8.7% WoW, while put OI grew by 8.6%.

[US Crude Oil Options Weekly 2025/10] WTI Extends Decline Amid Weak Demand and Trade Uncertainty

By Suhas Reddy

  • WTI futures fell by 3.9% for the week ending 07/Mar, marking its seventh consecutive weekly drop. Prices fell due to trade tensions, rising U.S. crude inventories, and demand concerns.
  • The U.S. rig count fell by one to 592, ending a five-week gain streak, with oil rigs unchanged at 486 and gas rigs down by one to 101.
  • WTI OI PCR fell to 0.91 on 07/Mar from 0.98 on 28/Feb. Call OI increased by 13.1% WoW, while put OI rose by 5.3%.

Gold’s Record Rally Meets Resistance: Will USD 3,000 Be the Breaking Point?

By Pranay Yadav

  • Geopolitical risk and central bank purchases continue to support gold demand, but rising Treasury yields present headwinds. Physical imports to the U.S. are plateauing, easing supply constraints.
  • Gold prices are facing resistance at USD 3,000/oz, with technical indicators suggesting potential consolidation before further upside. Historical patterns indicate similar conditions led to stagnant prices.
  • Gold leasing rates have normalized, signaling reduced supply stress. Previous spikes above 5% indicated a temporary supply shock, but the recent decline suggests a more balanced market.

Iron Ore Majors Guidance: Key To Understanding Supply Side in 2025

By Sameer Taneja

  • Iron ore majors guide flattish growth for 2025, while China continues to have strong iron ore imports (4.2% YoY for CY24), despite weak steel production (-1.1% YoY). 
  • Significant capacity growth commences in CY26 with the ramp-up of Rio Tinto Ltd (RIO AU)’s Simandou project, equivalent to 6% of global seaborne trade ~100 million tons.  
  • We believe the iron ore price will be rangebound until 2026 (between 100-120 USD/ton), after which it is highly probable that it will decline to 80-90 USD/ton.

YPF 4Q24: Macro Tailwinds and Strategic Progress Offset a Weak Quarter

By Leandro Gubler

  • We maintain our Outperform recommendation on YPF. Shale Expansion, Export Capacity Growth Key to Long-Term Performance
  • YPF posted weak 4Q24 results. Adjusted EBITDA dropping 38.6% QoQ and 22.5% YoY to $839 million, missing consensus by 19.7%.
  • YPF reaffirmed confidence in its strategic execution, achieving key milestones in shale operations, mature fields divestments, and fuel pricing adjustments.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Consumer: Seven & I Holdings, Goldlion Holdings, ATRenew , Sido Muncul, Betterware de Mexico Sab de CV, Unilever Nigeria, ContextLogic , Quantasing Group , Shimojima and more

By | Consumer, Daily Briefs

In today’s briefing:

  • 7&I (3382) Update – Couche-Tard Responds
  • Goldlion Holdings (533 HK) Privatization – The Offer Price Is Acceptable
  • RERE: 4Q24 Earnings – EPS as Expected Investing for Growth to Keep Pace with Accelerating Demand
  • Sido Muncul (SIDO IJ) – Increasingly Diversified Growth
  • BWMX: Snapping the Catalog: Growing Spring Confidence; Reiterate Buy, $22.50 PT
  • What’s News in Amsterdam – 11 March 2025 (Unilever | Fugro)
  • ContextLogic (LOGC)
  • QuantaSing Group Limited: EPS Beat on Higher Revenues/Operating Income
  • Shimojima (7482 JP) – OPM Rebounded from Q2 3.4% → Q3 8.6% on Price Hikes


7&I (3382) Update – Couche-Tard Responds

By Travis Lundy


Goldlion Holdings (533 HK) Privatization – The Offer Price Is Acceptable

By Xinyao (Criss) Wang

  • In recent years, Goldlion is facing performance headwinds. Both revenue and net profit have shown a downward trend due to declining consumption, real estate crisis and unfavorable external factors.
  • In short term, the weak consumer confidence and market momentum are unlikely to improve. Goldlion’s performance may gradually pick up in 2026 and 2027 but is still in downward trend.
  • Considering the low trading liquidity, weak fundamentals, uncertainties on performance brought by Goldlion’s potential strategic transformation and  the concerns on the outlook, we think the Cancellation Price is acceptable.

RERE: 4Q24 Earnings – EPS as Expected Investing for Growth to Keep Pace with Accelerating Demand

By Zacks Small Cap Research

  • Key 4Q24 takeaways include: 1) real-time step ups in trade-in activity and consumer demand for high-quality preowned products on the heels of recently introduced government subsidies and ongoing growth in the supply of new smartphone shipments continue to drive accelerating revenue growth 2) in response to building demand trends, management plans to continue to expand the company’s footprint (800 new store openings planned for this year), branding initiatives via new social media content/channels, and fulfillment capabilities and 3) while we assume adjusted operating income margins hold steady this year, our model calls for material margin expansion looking out to 2026, as revenue growth momentum continues to build and expense inflation moderates.

Sido Muncul (SIDO IJ) – Increasingly Diversified Growth

By Angus Mackintosh

  • Sido Muncul remains a standout consumer proxy in Indonesia through its Tolak Angin herbal brand playing into increased health consciousness and through its energy drinks exposure through Kuku Bima. 
  • The company continues to expand its product range in herbal, reducing its reliance on Tolak Angin. F&B is seeing stronger growth, with pharmaceuticals also becoming a more important driver.
  • Sido Muncul continues to expand its distribution locally across general trade and modern trade, with the international business outgrowing the local business and becoming more important. Valuation remains attractive.

BWMX: Snapping the Catalog: Growing Spring Confidence; Reiterate Buy, $22.50 PT

By Small Cap Consumer Research

  • We are reiterating our Buy rating, $22.50 price target and projections for Betterware de Mexico after reviewing the March 2025 catalog.
  • As has been the hallmark since 4Q24, March saw material increases in overall SKU count (up 5.8%) YoY and pricing (12.5% YoY increase).
  • That said, while overall prices increased, this month saw a slowdown in the rate of discounting, with the catalog registering less than 30% of total SKUs on sale; while still up YoY, March 2025 sales rate was the second lowest since August 2024.

What’s News in Amsterdam – 11 March 2025 (Unilever | Fugro)

By The IDEA!

  • In this edition: • Unilever | Mr Fernandez’ first statements as CEO signal the first signs of change • Fugro | to perform geotechnical site investigation for Blue Mackerel offshore wind farm

ContextLogic (LOGC)

By Triple S Special Situations Investing

  • ContextLogic Inc. (NASDAQ: LOGC) has transformed from an e-commerce operator to a cash-rich shell company possessing substantial tax assets, positioning it as a unique investment opportunity.
  • The company’s recent strategic partnership with BC Partners has created a significant value proposition for investors, particularly those seeking to navigate current market volatility.
  • This investment opportunity combines tangible cash assets with substantial tax benefits, all supported by sophisticated financial backing.

QuantaSing Group Limited: EPS Beat on Higher Revenues/Operating Income

By Zacks Small Cap Research

  • Key F2Q25 takeaways include: 1) senior executives remain focused on continually realigning/improving the online learning course catalog, and increasingly leveraging QSG’s existing online platform and customer base
  • 2) steady cash flows from the legacy online learning services platform continue to fund the strategic transition, with a focus on higher-quality products/services geared toward the silver demographic
  • 3) management continues to launch new health/wellness related products and services aimed at the silver demographic, while exploring opportunities across the consumer sector to enhance growth

Shimojima (7482 JP) – OPM Rebounded from Q2 3.4% → Q3 8.6% on Price Hikes

By Sessa Investment Research

  • While 1H profits struggled under pressure on COS from the weak yen, price hikes for roughly 80% of products were implemented from September, a portion from October, so Q4 will see a full 3-month contribution.
  • Note also success in controlling SG&A from Q3. Sapporo-based Ohkura Sangyo will be consolidated from Q1 FY26/3 with the acquisition completed in Jan-2025.
  • In this report, we look at three TOPICS. The first is an update on CY2024 booming inbound demand, which is continuing coming into 2025. 

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Health Care: Narayana Hrudayalaya Ltd, Shilpa Medicare, Ensysce Biosciences , Nippon Shinyaku and more

By | Daily Briefs, Healthcare

In today’s briefing:

  • The Beat Ideas: Narayana Hrudayalaya Ltd (NHL) ~ Driving Growth from India to Cayman Islands
  • The Beat Ideas: Shilpa Medicare
  • ENSC: NDA Submission in Sight
  • Nippon Shinyaku (4516 JP): Strong 9MFY25 Numbers; FY25 Guidance Raised; Regular Launches Remain Key


The Beat Ideas: Narayana Hrudayalaya Ltd (NHL) ~ Driving Growth from India to Cayman Islands

By Sudarshan Bhandari

  • Narayana Hrudayalaya Ltd (NARH IN) is a prominent player in the Indian healthcare sector, distinguished by its commitment to providing affordable, high-quality medical services.
  • The company established its first international hospital in the Cayman Islands in 2014, targeting patients from the Americas and Caribbean regions by offering competitively priced medical services
  • Management has outlined a capex guidance of around INR 4,000 crores over the next 3 to 4 years, funded by healthy cash flows and stable operating margins.

The Beat Ideas: Shilpa Medicare

By Sudarshan Bhandari

  • Shilpa Medicare (SLPA IN) will begin commercializing new molecules across segments, driving growth to new heights as older products are phased out, ensuring sustained progress and innovation in its business.
  • In recent years, the company has experienced growth stagnation and declining profitability due to US FDA issues affecting both the company and its key client in the API segment.
  • The company’s pipeline of new molecules offers significant growth potential, with a single successful molecule poised to elevate the company to unprecedented levels over the next five years.

ENSC: NDA Submission in Sight

By Zacks Small Cap Research

  • Ensysce Biosciences is committed to finding a solution to the opioid crisis plaguing the US and other developed countries around the world.
  • Through its proprietary TAAP technology Ensysce is in the process of receiving approval for an abuse-resistant yet still pain-relieving opioid.
  • The company announced 4Q2024 results that reflected good cash on hand as well as highlighting the progress for its signature non-opioid pain reliever and its plan for submitting an NDA.

Nippon Shinyaku (4516 JP): Strong 9MFY25 Numbers; FY25 Guidance Raised; Regular Launches Remain Key

By Tina Banerjee

  • During 9MFY25, Nippon Shinyaku (4516 JP) reported revenue growth of 8% YoY to ¥121B, while operating profit stood at ¥33B, up 8% YoY.
  • Viltepso witnessed growth both in Japan and the U.S. and licensing income also increased on higher overseas sales of Uptravi.
  • Guidance for FY25 have been raised with sales now expected to be ¥160B, up 8% YoY.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Financials: ESR Group , Korea Stock Exchange Kospi Index, Indusind Bank, SK Inc, Bank Of Baroda, Tejon Ranch , Yuexiu Property and more

By | Daily Briefs, Financials

In today’s briefing:

  • ESR (1821 HK) Chips Away At Pre-Cons
  • Properly Interpreting Korea’s Stock Borrow Data for Short Selling
  • IndusInd Bank (IIB IN): Stock Crashes on Derivatives Losses; Index Selling Next
  • Asia Real Estate Tracker (11-Mar-2025): Singapore buying Sydney office for $70M.
  • IndusInd Bank: Derivative Discrepancy Surfaces, Raising Governance Concerns
  • Bank of Baroda QIP Early Look – Well Flagged but Last Deal Did Not Do Well
  • TRC: Potential Upcoming Catalysts Include Opening of First Terra Vista Units
  • Lucror Analytics – Morning Views Asia


ESR (1821 HK) Chips Away At Pre-Cons

By David Blennerhassett

  • When the Starwood/Warburg Pincus Consortium announced a firm offer on the 4th December, it was pre-conditional on a raft of regulatory approvals from no less than eight countries/jurisdictions. 
  • We’re half way there, with four approvals now squared away, leaving Australia, China, Hong Kong and New Zealand still to give the go ahead. 
  • Irrevocables comprising 34.26% of the register (and 57.01% of disinterested shares) are now in the bag. This is a done deal. It’s just a question of timing.

Properly Interpreting Korea’s Stock Borrow Data for Short Selling

By Sanghyun Park

  • Local instos borrow from brokers or peers, KSD collects and cleans the data, then KOFIA reports stock borrow balances daily with a two-day lag.
  • Offshore borrows via EquiLend or PB deals don’t show up—KSD reporting only covers local institution-to-institution stock loans.
  • Assume 60% of reported borrow balance is real shortable ammo—adjusting for this helps filter out noise in short positioning.

IndusInd Bank (IIB IN): Stock Crashes on Derivatives Losses; Index Selling Next

By Brian Freitas

  • The Indusind Bank (IIB IN) stock was down 27% yesterday following the announcement of Derivatives Portfolio losses that have wiped out 2.35% of equity.
  • Foreign investors were big sellers in the last 3 months of 2024. That led to increased foreign room, leading to an index upweight in February and index inclusion in March.
  • The drop in market cap and free float market cap will see Indusind Bank (IIB IN) deleted from the S&P BSE SENSEX Index in June and the NIFTY Index in September.

Asia Real Estate Tracker (11-Mar-2025): Singapore buying Sydney office for $70M.

By Asia Real Estate Tracker

  • Cambridge, a Singapore-based firm, purchases a Sydney office block for $70M from a former Tysan boss, expanding its real estate portfolio
  • Hong Kong Land reports a significant increase in losses, totaling $1.4B, attributed to challenges within its Central Portfolio
  • M&G Real Estate invests $62M in student housing in Melbourne, Australia, highlighting their focus on the Australian real estate market. Warburg Pincus forms a partnership with SK Group to develop Korean senior living facilities, tapping into the growing demand for elderly care in South Korea.

IndusInd Bank: Derivative Discrepancy Surfaces, Raising Governance Concerns

By Nimish Maheshwari

  • IndusInd Bank recently disclosed a significant accounting discrepancy in its derivatives portfolio, estimated to impact its net worth by INR 1,580 crore (~2.35%). 
  • The issue pertains to internal trades executed over the past 7–8 years, now identified through a detailed internal review initiated following regulatory changes.
  • This development, when viewed alongside the abrupt CFO exit, regulatory pushback on CEO tenure, and existing operational challenges, raises concerns around internal controls, risk governance, and management credibility.

Bank of Baroda QIP Early Look – Well Flagged but Last Deal Did Not Do Well

By Akshat Shah

  • Bank Of Baroda (BOB IN) is looking to raise about INR 85bn (US$980m) in its upcoming qualified institutional placement (QIP).
  • In an announcement released on Feb 13, 2025, BOB mentioned its board’s approval to raise upto INR85bn via various modes including a QIP. Since then, the shares have corrected 1.2%.
  • The deal would be a relatively large one to digest at 39 days of three month ADV. The company’s last fundraise did not do well.

TRC: Potential Upcoming Catalysts Include Opening of First Terra Vista Units

By Zacks Small Cap Research

  • The convenience and affordability of Terra Vista housing, as well as proximity to LA, are expected to drive demand from TRCC employees and others.
  • The development of the nearby Hard Rock Hotel & Casino Tejon is another likely driver of demand for affordable housing from its employees.
  • Upon completion, Terra Vista at Tejon is expected to be the largest rental community in Kern County.

Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Yuexiu Property, Adani Energy Solutions
  • In the US, treasuries climbed on safe-haven demand and increased expectations of Fed rate cuts, amid growing concerns over the US economy. The UST curve bull-steepened, with the yield on the 2Y UST declining 12 bps to 3.89%, while the yield on the 10Y UST fell 9 bps to 4.22%. Fed-dated OIS were pricing in 81 bps of rate cuts this year, with the first decrease expected in June.
  • Equities sank on rising economic uncertainty, given rising trade tensions and after US President Donald Trump’s comments that the economy is facing a “period of transition” this year. The S&P 500 fell 2.7% to 5,615, while the Nasdaq slid 4.0% to 17,468.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief ECM: Pre-IPO Huge Dental Limited – The Business and the Concerns Behind and more

By | Daily Briefs, ECM

In today’s briefing:

  • Pre-IPO Huge Dental Limited – The Business and the Concerns Behind
  • Anjoy Foods Group A/H Listing – A Leader in a Fragmented Industry


Pre-IPO Huge Dental Limited – The Business and the Concerns Behind

By Xinyao (Criss) Wang

  • Since HUGE ranks in the first tier among domestic brands, the import substitution would be the main logic to continue driving the performance growth based on its strong cost effectiveness.
  • If HUGE wants to achieve success in non-advantageous areas in the future, reducing price to compete for more market share could be an essential means. VBP is also a challenge.
  • Comparable companies include Sinocera Functional Material, Yantai Zhenghai Bio-Tech, Angelalign, Modern Dental Group, Topchoice Medical. We think valuation of HUGE could be higher than peers due to higher profitability.

Anjoy Foods Group A/H Listing – A Leader in a Fragmented Industry

By Sumeet Singh

  • Anjoy Foods Group (603345 CH), a quick-frozen food company in China, aims to raise around US$300m in its H-share listing.
  • AFG was the largest quick-frozen food company in China in terms of revenue in 2023, with a market share of 6.2%, according to the Frost & Sullivan report. 
  • In this note, we look at its past performance and other deal dynamics that might impact the listing.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Thematic (Sector/Industry): Chartered Insights: Which Asian Economies Face the Greatest Threat from US Reciprocal Tariffs? and more

By | Daily Briefs, Thematic (Sector/Industry)

In today’s briefing:

  • Chartered Insights: Which Asian Economies Face the Greatest Threat from US Reciprocal Tariffs?
  • Ohayo Japan | Wall Street Rout Deepens
  • Who Is Crazy Enough to Buy a Chinese Bank?
  • Japan Morning Connection: Bloodbath for Tech and Continued Pivot from Growth to Value
  • Can India Achieve Advanced Economy Status by 2047? – IMF Report
  • What Ultratech’s Foray into Wires & Cables Means for Industry Dynamics, Competition, and Growth
  • Biopharma Week in Review – March 10, 2025


Chartered Insights: Which Asian Economies Face the Greatest Threat from US Reciprocal Tariffs?

By Sudarshan Bhandari

  • Trump’s tariffs are set to impact Asia, especially economies like Vietnam who stand out with a substantial 25.1% of its GDP exposed to the US market in 2024.
  • India and Thailand face reciprocal tariff risks, while sectors like food and textiles may bear the brunt.
  • Beyond direct tariffs, non-tariff barriers in China and India and potential inflation in the US add complexity.

Ohayo Japan | Wall Street Rout Deepens

By Mark Chadwick

  • Stocks plunged Monday as recession fears mounted, with the S&P 500 dropping 2.7% to 5,614 and the Nasdaq sinking 4%
  • The “Magnificent Seven” led losses, with Tesla (TSLA) plummeting 15%, Nvidia (NVDA) down 5%, and Alphabet (GOOGL) and Meta (META) losing over 4%
  • Seven &i Holdings responds to shareholder Artisan Partners’ opposition to the appointment of Stephen Hayes Dacus as president

Who Is Crazy Enough to Buy a Chinese Bank?

By Rikki Malik

  • A stealth bull market is underway in Chinese bank shares 
  • Banks are well positioned to benefit as the economy grows and interest rates rise
  • Value remains in the sector despite the  move up in share prices

Japan Morning Connection: Bloodbath for Tech and Continued Pivot from Growth to Value

By Andrew Jackson

  • Japan’s SPE rebound yesterday led by Lasertec -10% may be short lived.
  • However, NVDA’s week-long developers conference from Monday may act as dip buying catalyst.
  • Still room for EU related plays to gain with many related names inherently defensive.

Can India Achieve Advanced Economy Status by 2047? – IMF Report

By Nimish Maheshwari

  • The IMF projects India as the fastest-growing major economy, with a 6.5% GDP growth rate, but can it achieve advanced economy status by 2047?.
  • Balancing fiscal prudence with investments in infrastructure, while leveraging AI for productivity, is critical for India’s transformation.  
  • Structural reforms, increased private investment, and managing global risks will determine if India realizes its vision by 2047.

What Ultratech’s Foray into Wires & Cables Means for Industry Dynamics, Competition, and Growth

By Sudarshan Bhandari

  • UltraTech Cement is entering the Wires & Cables industry with a INR 1,800 crore investment and a plant in Gujarat, aiming for INR 9,000 crore in revenue by 2030. 
  • With strong backward integration and an extensive distribution network, the move could disrupt a fragmented market. 
  • However, incumbents believe scaling and regulatory approvals will be key hurdles, much like Grasim’s entry into paints.

Biopharma Week in Review – March 10, 2025

By Water Tower Research

  • Market uncertainty and further disruptions at health agencies led to continued divergence between SMID-cap and large biopharma, as investors sought shelter in lower- risk, higher-quality names.
  • Trump nominees, Martin Makary for the FDA and Jay Bhattacharya for the NIH, appeared on course for Senate confirmations after relatively uncontentious hearings, but both provided little confidence that they would stop or reverse the draconian changes at these agencies.
  • NIH grant funding has not resumed despite a judge ruling against the cuts. RFK Jr. changed his stance on the measles outbreak, from not unusual to deeply concerned, as the second death occurred in an unvaccinated adult.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Event-Driven: 7&I (3382) – Artisan Writes (Again) And 7&I Updates (Again) – More Positive Outlook Now and more

By | Daily Briefs, Event-Driven

In today’s briefing:

  • 7&I (3382) – Artisan Writes (Again) And 7&I Updates (Again) – More Positive Outlook Now
  • Seven & I Holdings (3382 JP): Reading Between the Lines of the Public Letter
  • Makino Milling Machine (6135 JP): A White Knight Bidder Is Emerging
  • Young Poong: Announces Cancellation of Entire Treasury Shares and 10:1 Stock Split
  • Insignia Financial (IFL AU): Bain and CC Capital Bumps to A$5.00, While Brookfield Drops Out
  • Sun Pharmaceutical (SUNP IN): Checkpoint Acquisition Does Not Check All the Boxes
  • Sell Kenvue + What I’m Buying


7&I (3382) – Artisan Writes (Again) And 7&I Updates (Again) – More Positive Outlook Now

By Travis Lundy

  • On Thursday 6 March we got a Nikkei article then a company announcement for Seven & I Holdings (3382 JP)‘s proposed management measures and update on ACT Bid Process.  
  • It involved Isaka-san stepping down, Stephen Dacus stepping up, selling York to Bain for ¥814.7bn, IPOing 7-Eleven US, a ¥2trln share buyback over 5yrs, and ACT process update. 
  • It was OK. Good, bad, and ugly. But Artisan wrote a letter over the weekend and 7&i responded and suddenly, their concerns are mostly addressed and the outlook is different.

Seven & I Holdings (3382 JP): Reading Between the Lines of the Public Letter

By Arun George

  • The Seven & I Holdings (3382 JP) Board has released a public letter to address Artisan Partners’ letter and provide more details on the Alimentation Couche-Tard (ATD CN) constructive engagement. 
  • The letter effectively addresses most of Artisan’s concerns. The Board is engaging with Couche-Tard, particularly by agreeing on a strategy to find a solution to secure antitrust approvals. 
  • However, the statement suggests that the Board retains deep scepticism that the Couche-Tard is viable and is manoeuvring to shift the blame on a failed bid on a flawed proposal. 

Makino Milling Machine (6135 JP): A White Knight Bidder Is Emerging

By Arun George

  • Makino Milling Machine Co (6135 JP) has disclosed that it has received initial letters of intent from multiple third parties, reportedly private equity funds, to launch a competing tender offer.
  • My analysis suggests that a white knight bid could be as high as JPY13,284, 20.8% higher than Nidec’s JPY11,000 offer and 10.2% higher than the last close price of JPY12,050.
  • Nidec Corp (6594 JP) will take a wait-and-see approach. However, regardless of whether a white knight bidder emerges, Nidec will eventually have to bump.

Young Poong: Announces Cancellation of Entire Treasury Shares and 10:1 Stock Split

By Douglas Kim

  • On 10 March, Young Poong (000670 KS) announced that it plans to cancel all of its treasury shares and conduct a 10-to-1 stock split.
  • Driven by the treasury shares cancellation and stock split, Young Poong’s share price rose 8.9% to 489,000 won today (10 March 2025). 
  • Our updated NAV of Young Poong suggests NAV per share of 834,064 per share, representing a 71% upside from current levels.

Insignia Financial (IFL AU): Bain and CC Capital Bumps to A$5.00, While Brookfield Drops Out

By Arun George

  • On 7 March, Insignia Financial (IFL AU) disclosed a revised non-binding privatisation offer from Bain and CC Capital at A$5.00, an 8.7% premium to their previous A$4.60 offer.
  • The exclusive due diligence period ends on 17 April (six weeks from signing the exclusivity deed). The Board will recommend a binding offer of at least A$5.00. 
  • The offer is attractive compared to historical trading ranges, peer multiples and precedent transactions. Therefore, a binding offer would gain shareholder support.

Sun Pharmaceutical (SUNP IN): Checkpoint Acquisition Does Not Check All the Boxes

By Tina Banerjee

  • Sun Pharmaceutical Industries (SUNP IN) (SPIL) announced the plan to acquire Checkpoint Therapeutics (CKPT US), a commercial stage immunotherapy and targeted oncology company, for ~$200M.
  • In December, Checkpoint has received FDA approval for its maiden drug, Unloxcyt (cosibelimab), for the treatment of certain type of skin cancer. Unloxcyt has peak sales estimate of $1.6B.
  • SPIL’s offer for Checkpoint seems compelling and provides superior risk-adjusted value. However, the acquisition will not be near-term value generator for SPIL, which doesn’t have good track record for acquisition.

Sell Kenvue + What I’m Buying

By Richard Howe

  • I’m closing out my Kenvue (KVUE) recommendation and will be selling my shares.

  • Following the spin-off from Johnson & Johnson (JNJ), KVUE shares performed poorly for a variety of reasons (lockluster growth, Tylenol related litigation, etc.) that I thought were overblown.

  • At the time, Kenvue was trading at a sharp discount to its consumer health care peers. Today, Kenvue trades at a slight discount to peers (21 P/E vs. 23.3x for the group).


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Credit: Bharti Airtel – ESG Report – Lucror Analytics and more

By | Credit, Daily Briefs

In today’s briefing:

  • Bharti Airtel – ESG Report – Lucror Analytics
  • Lucror Analytics – Morning Views Asia


Bharti Airtel – ESG Report – Lucror Analytics

By Trung Nguyen

Bharti Airtel is the second-largest telecom player in India, with a c. 30% market share. It also has significant operations in Africa, and to a smaller extent Bangladesh and Sri Lanka. The largest shareholders are Bharti Enterprises (42%) and Singtel (14%). Bharti Enterprises was founded/owned by Sunil Bharti Mittal. It is one of India’s first conglomerates, with interests in telecommunications, space, insurance, real estate, hospitality and food.

We view Bharti Airtel as “Low Risk” on the LARA scale, mainly given its strong market position as the second-largest player in India’s telecom industry. The company owns robust network infrastructure across the country, with a broad customer base. We also note positively the improving industry outlook, with rationalising competition and industry consolidation benefiting Bharti Airtel, along with improving regulatory conditions. The company is committed to prudent balance-sheet management and stable leverage. However, capex requirements will likely remain substantial given Bharti Airtel’s 5G rollout, with a risk that capex will be higher than projected.


Lucror Analytics – Morning Views Asia

By Leonard Law, CFA

  • In today’s Morning Views publication we comment on developments of the following high yield issuers: Longfor Group, Melco Resorts, Sands China, Tata Motors
  • In the US, February nonfarm payrolls increased to 151 k (160 k e / 125 k revised p), albeit the figure came in slightly below estimates. Moreover, the January number was revised downwards to 125 k (143 k p), with the two-month revision at negative 2 k (+100 k p). The unemployment rate edged up to 4.1% (4.0% e / 4.0% p). The average hourly earnings rose 0.3% m-o-m (0.3% e / 0.4% revised p) and 4.0% y-o-y (4.1% e / 3.9% revised p).

  • Fed Chairman Jerome Powell has reiterated that the US central bank is in no rush to reduce rates. He said: “Despite elevated levels of uncertainty, the US economy continues to be in a good place”, adding that “sentiment readings have not been a good predictor of consumption growth in recent years”.


💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Equity Bottom-Up: Xiaomi (1810 HK): 4Q24 Preview and more

By | Daily Briefs, Equity Bottom-Up

In today’s briefing:

  • Xiaomi (1810 HK): 4Q24 Preview, All Businesses Healthy, But Vehicle Overvalued
  • Alibaba Group’s AI Power Move—Can It Outpace DeepSeek and OpenAI?
  • Sea Ltd (SE US) – Shifting into Overdrive
  • Southern Company: Is The Growth in Southern Power’s Asset Portfolio Sustainable?
  • Seeking Value and Safety in HK/China: SHKP 16 HK
  • Coal India (COAL IN) Value Trap
  • SITC International (1308 HK): Another Strong Year, with Excellent Yield
  • Tech Supply Chain Tracker (11-Mar-2025): Global smartphones in 4Q 2024
  • Cisarua Mountain Dairy (CMRY IJ) – New Variants and Channels
  • China Bans Illumina’s Gene Sequencers Amid Escalating Trade Sanctions


Xiaomi (1810 HK): 4Q24 Preview, All Businesses Healthy, But Vehicle Overvalued

By Ming Lu

  • We believe all business, including smartphone and vehicle, will grow strongly in 4Q24 and 2025.
  • We expect EPS will increase by 15% YoY in 4Q24 and 41% in 2025.
  • However, we believe the market overvalues the newly launched vehicle business.

Alibaba Group’s AI Power Move—Can It Outpace DeepSeek and OpenAI?

By Baptista Research

  • Alibaba Group Holding has made a significant move in the AI space with the release of its latest artificial intelligence model, QwQ-32B, as it seeks to establish itself as China’s leading AI developer, challenging DeepSeek.
  • The model, which excels in mathematical reasoning, coding, and problem-solving, demonstrates capabilities comparable to both DeepSeek’s R1 and OpenAI’s latest technology.
  • However, a key differentiator is its size, as QwQ-32B operates with only 32 billion parameters compared to DeepSeek R1’s 671 billion.

Sea Ltd (SE US) – Shifting into Overdrive

By Angus Mackintosh

  • Sea Ltd booked a blowout set of results, with strong growth and profitability across all three divisions, surpassing previous guidance and bringing about the second profitable year for the company. 
  • E-Commerce was the key feature, with GMV surpassing US$100bn with increasing take rates, with core marketplace GAAP Revenues booking nearly +50% YoY growth in 4Q2024, confirming Shopee’s lead position. 
  • Digital Financial Services and Digital Entertainment also booked strong growth, with management highlighting a positive outlook for all three segments in 2025. Sea Ltd remains a core holding. 

Southern Company: Is The Growth in Southern Power’s Asset Portfolio Sustainable?

By Baptista Research

  • Southern Company reported strong performance for the fourth quarter of 2024, with adjusted earnings per share (EPS) reaching $4.05, marking an 11% growth from the previous year and positioning itself at the top of the 2024 guidance range.
  • This success is attributed to steady investments in state-regulated utilities and the successful management of weather-related impacts.
  • Positives from the earnings report include the addition of 57,000 new residential electric customers and 26,000 new customers in natural gas distribution businesses, reflecting robust growth, particularly in the Southeast.

Seeking Value and Safety in HK/China: SHKP 16 HK

By Jacob Cheng

  • MSCI China has rallied 19% YTD, outperforming DM and EM by 18% and 14% respectively.  We think it makes sense to look at China and Hong Kong again
  • Part of the rally is driven by AI optimism.  In terms of fund flow, we are seeing increasing south-bound fund flow to HK equity market at a fast pace
  • We think Sun Hung Kai Properties, which is a proxy for Hong Kong, may benefit and play the catch up game on the back of very attractive valuation

Coal India (COAL IN) Value Trap

By Rahul Jain

  • COAL’s production growth during Apr-Feb 25 has slowed to 1.5% yoy due to a high base effect and is unlikely to grow significantly in the near future
  • Regulated pricing mechanism means low correlation to international price movements. E-auction (10-12% of volumes) prices crash -25% yoy in line with international trends, impacting profitability
  • Single digit PE is in line with historic multiples. Wage renegotiations due in June 2026, rising coal production from captive producers, surge in renewable capacities are headwinds

SITC International (1308 HK): Another Strong Year, with Excellent Yield

By Osbert Tang, CFA

  • SITC International (1308 HK)‘s 93.5% profit growth in FY24 is at the top-end of the positive profit alert. A final DPS of HK$1.4 put it on a 7.3% dividend yield. 
  • The FY25 long-term contract rate is expected to rise 10%, with volume growing at least 5% and lower costs. The consensus forecast of a 23.1% earnings decline is too conservative. 
  • Having an ROE of 32% for FY25F, its 12-month forward P/B of 2.46x (vs. average of 2.59x) with net cash equals 5.4% of market capitalisation are inexpensive. 

Tech Supply Chain Tracker (11-Mar-2025): Global smartphones in 4Q 2024

By Tech Supply Chain Tracker

  • Global smartphone market expected to see substantial growth in 4th quarter of 2024, indicating a positive trend for the industry.
  • TSMC experiences a drop in revenue in Q1, as AI sector continues to expand and company addresses discrimination allegations.
  • AMD CEO recognizes value of open-source technology in DeepSeek, while HP announces plans to reduce workforce by cutting 2,000 jobs, reflecting industry challenges.

Cisarua Mountain Dairy (CMRY IJ) – New Variants and Channels

By Angus Mackintosh

  • Cisarua Mountain Dairy booked a strong finish to the year in terms of sales growth despite a high base driven by premium consumer foods, but with dairy showing recovery. 
  • The company saw an improvement in gross margins in 4Q2024 driven by the stabilization of raw materials and product mix, but operating margins were impacted by higher promotional spending..
  • Cimory will drive future growth by expanding across channels, especially general trade and with the launch of new products in both dairy and consumer food segments. Valuations remain attractive.

China Bans Illumina’s Gene Sequencers Amid Escalating Trade Sanctions

By Caixin Global

  • China has banned Illumina, the U.S. genomics giant, from exporting gene sequencing machines to the country, escalating sanctions imposed last month when the company was added to Beijing’s Unreliable Entity List.
  • The move is expected to accelerate domestic alternatives in the gene sequencing industry.
  • Illumina, a dominant player in the global gene sequencing industry, has been a major supplier in China since entering the market in 2005. It once held a near-monopoly in the country’s gene sequencing sector before Chinese rival MGI Tech Co. Ltd. emerged in 2015 as a competitor. Since then, the two companies have battled for market share in China while engaging in global patent disputes.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars



Daily Brief Crypto: End of The “dot-crypto” Era and more

By | Crypto, Daily Briefs

In today’s briefing:

  • End of The “dot-crypto” Era


End of The “dot-crypto” Era

By Etherbridge

  • Our short term view for 2025 was boring or scary.
  • February threw boring out of the window, in less than two months we have seen trade war scares, politicians launching and rug-pulling memecoins, politicians tweeting about crypto strategic reserves, a massive exchange exploit and downside economic surprises.
  • Price action through these events has been scary, at the beginning of February we saw a massive liquidation across cryptoassets, with some remarkable recoveries.

💡 Before it’s here, it’s on Smartkarma

Sign Up for Free

The Smartkarma Preview Pass is your entry to the Independent Investment Research Network

  • ✓ Unlimited Research Summaries
  • ✓ Personalised Alerts
  • ✓ Custom Watchlists
  • ✓ Company Data and News
  • ✓ Events & Webinars